Morgan Stanley Ceases >5% Beneficial Ownership in CervoMed (NASDAQ: CRVO)

Rhea-AI Filing Summary

CervoMed Inc shareholders were updated when Morgan Stanley and Morgan Stanley Capital Services LLC amended their Schedule 13G filings to report reduced holdings. Morgan Stanley reports 0.1% of the class with 10,000 shared voting power and 12,550 shared dispositive power; Morgan Stanley Capital Services LLC reports 0.0%.

The filing states both entities "have ceased to be the beneficial owner of more than five percent of the class of securities." The amendment is signed by an authorized signatory and includes exhibits for a joint filing agreement and Item 7 subsidiary details.

Insights

Institutional Ownership Analyst

Large institutional holder reports sub‑5% ownership after amendment.

The amendment shows Morgan Stanley holds 0.1% of CervoMed common stock with 10,000 shared voting power and 12,550 shared dispositive power as reported on the cover pages. It also shows Morgan Stanley Capital Services LLC at 0.0%.

This filing documents a reduction in reportable ownership under Schedule 13G/A; transaction timing and methods are not stated in the excerpt. Subsequent filings or exhibits may provide subsidiary attribution and the Item 7 exhibit referenced.

Compliance & Disclosure Specialist

Amendment aligns with Section 13 reporting thresholds and includes required exhibits.

The filing cites Release No. 34-39538 and attaches Exhibit 99.1 (Joint Filing Agreement) and Exhibit 99.2 (Item 7 information). Signatures from an authorized signatory are provided with dated execution.

Disclosure language explicitly states the entities "ceased to be the beneficial owner of more than five percent of the class of securities," preserving the formal threshold disclosure; readers should reference Exhibit 99.2 for subsidiary classification details.

Key Figures

Morgan Stanley percent of class: 0.1% Morgan Stanley shared voting power: 10,000 shares Morgan Stanley shared dispositive power: 12,550 shares +2 more

5 metrics

Morgan Stanley percent of class 0.1% Item 4 ownership percentage reported in amendment

Morgan Stanley shared voting power 10,000 shares Cover page Item 6 shared voting power

Morgan Stanley shared dispositive power 12,550 shares Cover page Item 8 shared dispositive power

Morgan Stanley Capital Services LLC percent of class 0.0% Cover page ownership percentage reported for MS Capital Services

Filing execution date 07/08/2026 Signatures dated on the amendment

Key Terms

Schedule 13G/A, Beneficial owner, Shared dispositive power, Joint Filing Agreement (Exhibit 99.1)

4 terms

Schedule 13G/A regulatory

"Amendment No. 2 and cover page showing beneficial ownership disclosure"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficial owner regulatory

"Statement: 'ceased to be the beneficial owner of more than five percent of the class of securities.'"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

Shared dispositive power financial

"Cover page fields showing 'Shared Dispositive Power 12,550.00'"

Joint Filing Agreement (Exhibit 99.1) regulatory

"Exhibit Information lists 99.1 Joint Filing Agreement"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/08/2026 - 05:43 PM Accepted by SEC EDGAR 07/08/2026 - 05:43 PM Learn about SEC filing dates

FAQ

What does Morgan Stanley report holding in CervoMed (CRVO)?

Morgan Stanley reports 0.1% of CervoMed common stock with 10,000 shared voting power and 12,550 shared dispositive power. The amendment states it has ceased to be a beneficial owner of more than five percent.

What does Morgan Stanley Capital Services LLC report in the filing?

Morgan Stanley Capital Services LLC reports 0.0% beneficial ownership of CervoMed common stock. The cover page comment states it has ceased to be the beneficial owner of more than five percent of the class.

Does the filing explain why ownership dropped below 5%?

The amendment states the entities "have ceased to be the beneficial owner of more than five percent" but does not provide reasons, transaction timing, or methods in the excerpt. Exhibit 99.2 may include subsidiary identification details.

Who signed and dated the Schedule 13G/A amendment for Morgan Stanley?

The amendment is signed by Claire Gordon as Authorized Signatory for both Morgan Stanley and Morgan Stanley Capital Services LLC, with execution dates of 07/08/2026 shown on the filing.

What exhibits accompany this Schedule 13G/A amendment?

The filing lists Exhibit 99.1 as the Joint Filing Agreement and Exhibit 99.2 as Item 7 information concerning subsidiary identification and classification, per the cover page reference.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

CervoMed Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

15713L109

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 15713L109

1

Names of Reporting Persons

Morgan Stanley

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 10,000.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 12,550.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

12,550.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.1 %

12

Type of Reporting Person (See Instructions)

HC, CO

Comment for Type of Reporting Person: As of the date hereof, Morgan Stanley has ceased to be the beneficial owner of more than five percent of the class of securities.

SCHEDULE 13G

CUSIP Number(s): 15713L109

1

Names of Reporting Persons

Morgan Stanley Capital Services LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

BD, CO

Comment for Type of Reporting Person: As of the date hereof, Morgan Stanley Capital Services LLC has ceased to be the beneficial owner of more than five percent of the class of securities.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: CervoMed Inc
(b)	Address of issuer's principal executive offices: 20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
Item 2.
(a)	Name of person filing: 1: Morgan Stanley 2: Morgan Stanley Capital Services LLC
(b)	Address or principal business office or, if none, residence: 1: 1585 Broadway, New York, NY 10036 ;2: 1585 Broadway, New York, NY 10036
(c)	Citizenship: 1: Delaware 2: Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 15713L109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s).
(b)	Percent of class: 0.1 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s).
	(ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s).
	(iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s).
	(iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s).
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit 99.2
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. * In Accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley and its subsidiaries and affiliates (collectively, "MS"). This filing does not reflect securities, if any, beneficially owned by any operating units of MS whose ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Morgan Stanley

Signature:	Claire Gordon
Name/Title:	Authorized Signatory, Morgan Stanley
Date:	07/08/2026

Morgan Stanley Capital Services LLC

Signature:	Claire Gordon
Name/Title:	Authorized Signatory, Morgan Stanley Capital Services LLC
Date:	07/08/2026

Exhibit Information

EXHIBIT NO. EXHIBITS ------------------ ------------------------------------ 99.1 Joint Filing Agreement 99.2 Item 7 Information * Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001).